Meet Dr Lay Tay
Dr Lay Tay is a specialist in haematology, her main interests are anaemia, haemostasis and thrombosis. She also treats patients with malignant conditions such as myelodysplasia, lymphoma, leukaemia and myeloproliferative disorders.
She had many years of experience working in tertiary teaching hospitals, Royal Prince Alfred (RPA) and Royal North Shore (RNS), and during this time she developed interests in research and clinical trials. She has also worked in haemophilia treatment centres and thalassaemia units in both Sydney and Adelaide and involved in clinical trials of both conditions.
More recently, when she was working in NSW Mid-North Coast and New Zealand, she was involved in clinical trials of myelofibrosis and myeloma.
She is fluent in English, as well as other languages or dialects including Mandarin, Cantonese and Hokkien.
She had many years of experience working in tertiary teaching hospitals, Royal Prince Alfred (RPA) and Royal North Shore (RNS), and during this time she developed interests in research and clinical trials. She has also worked in haemophilia treatment centres and thalassaemia units in both Sydney and Adelaide and involved in clinical trials of both conditions.
More recently, when she was working in NSW Mid-North Coast and New Zealand, she was involved in clinical trials of myelofibrosis and myeloma.
She is fluent in English, as well as other languages or dialects including Mandarin, Cantonese and Hokkien.
PUBLICATIONs
More to read...
- Assessing lymphadenopathy in adults: a systemic approach – Medicine Today, Nov 2004
- Investigating thalassaemia and haemoglobinopathy – IMVS Newsletter, No 71-2009, SA
- Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia - Pubmed Semin Thromb Hemost. 2009 Nov;35(8):769-77
- Thirty years experience of joint replacements in patients with bleeding disorder in South Australia - SA RAH HTC team, patients and data (15th Australia and NZ Haemophilia Conference 2009)
- A Phase 1 Dose-Escalation Study: Safety, Tolerability, And Pharmacokinetics Of FBS0701, A Novel Oral Iron Chelator For The Treatment Of Transfusional Iron Overload - Haematologica April 2011 96:521-525
- A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients with Haemoglobinopathies, Myelodysplastic Syndromes or Other Anaemias Treated with Deferasirox (the MILE study CICL670AAU01) – Results of An Interim Analysis At a Planned Sample Size Reassessment - ASH annual meeting 2011 abstract
WHAT I READ THAT MAY BE OF INTEREST TO YOU...
Under construction...
Coming Soon...
| ||||||
Contact Us
(Practice is open on Wednesday only)
You can also request an appointment on line by completing and submitting this form.
You can also request an appointment on line by completing and submitting this form.
ChatswoodLevel 1, Suite 105,
443 Victoria Avenue Chatswood NSW 2067 (Chatswood Nuclear Medicine & Endocrinology) Parking: Metered street parking is available or park in nearby shopping centres such as Westfield Chatswood or Mandarin Centre. |
WaterlooGreen Square Specialist Centre,
Suite C1, 30-36 O’Dea Avenue, Waterloo NSW 2017 (corner of Sam Sing Street and O'Dea Avenue) Parking: Available on site for patients. Press 01 and OK for entry, keep to left till next to lift, go to level 1 Cafe available on ground floor, Coffee Philosophy |
02 8076 9260
0416 590 526 
02 81972302
PO Box 674
Chatswood NSW 2067 
info@redblood.com.au
|